Clinical Trial Update: A Dose-finding Study to Evaluate mRNA-3210 in Participants With Phenylketonuria [Phase 1, Phase 2]

View source ↗

Summary

A dose-finding study of mRNA-3210 for phenylketonuria (Phase 1/Phase 2) has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Phenylketonuria

Drugs mentioned

• mRNA-3210

Snippet

Sponsor: ModernaTX, Inc. | Conditions: Phenylketonuria | Phase 1, Phase 2 | Status: WITHDRAWN